Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 83301, Taiwan
NCT Number: NCT04285762
LVA orientations such as lymphaticovenous end-to-end (LVEEA), end-to-side (LVESA), and side-to-end (LVSEA) are commonly performed. Each orientation has its own advantages and disadvantages. The key factors affecting the type of anastomotic orientation are the sizes of the LVs and the RVs, and the relative distance between them. Most published literatures have focused on LVSEA2-9, which is considered to be the most efficient. With one anastomosis in LVSEA, the RV is able to drain both the antegrade and retrograde lymphatic flow. Nevertheless, how to determine the anastomotic orientation has remained ambiguous. In this study, we aimed to establish the basis of selecting the proper anastomotic orientation, based on the size and comparative size discrepancy between LV and RV. To the best of our knowledge, this is the first report to focus on this subject.
Looking for future studies?
Notify Me20 year–100 year
All sexes
Observational
Kaohsiung City, 83301, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
lymphaticovenous end-to-end
lymphaticovenous end-to-side
lymphaticovenous side-to-end
Time frame: up to 3 months
The primary free flap outcome was determined as its survival or failure.
Chang Gung Memorial Hospital
Other
Supermicrosurgical Lymphatic Venous Anastomosis for Lymphedema Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07414615
Hemic and Lymphatic Diseases, Lymphatic Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06905639
Behavior, Breast Diseases
Ponferrada, León, Spain
View Trial DetailsNCT02506530
Breast Diseases, Breast Neoplasms
Toulouse, Midi Pyrenees, France
View Trial DetailsNCT07612865
Cardiovascular Diseases, Cervical Cancer
Ürümqi, Xinjiang Uygur Autonomous Region, China
View Trial Details